Cargando…
Cytokine Release Syndrome (CRS) in Severe COVID-19 Patients: Two Controversial and Interesting Case Reports and Literature Review
BACKGROUND: Cytokine release syndrome (CRS) represents a potentially life-threatening and systematic inflammatory response where it is noted an increase of secretion of proinflammatory cytokines from lymphocytes, myeloid cells like macrophages, dendritic cells, and monocytes. This syndrome is charac...
Autores principales: | Lazovic, Biljana, Dmitrovic, Radmila, Simonovic, Isidora, Esquinas, Antonio M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618577/ https://www.ncbi.nlm.nih.gov/pubmed/37920307 |
Ejemplares similares
-
Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
por: Gonzalez-Rubio, Jesus, et al.
Publicado: (2020) -
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
por: Leclercq-Cohen, Gabrielle, et al.
Publicado: (2023) -
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
por: Pasrija, Ritu, et al.
Publicado: (2021) -
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
por: Stewart, Mark D., et al.
Publicado: (2022) -
Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)